Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (1)
  • Androgen Receptor
    (1)
  • Estrogen Receptor/ERR
    (1)
  • HER
    (1)
  • Opioid Receptor
    (1)
  • Sigma receptor
    (1)
  • iGluR
    (1)
  • Others
    (18)
Filter
Search Result
Results for "

target/Cannabinoid_Receptor/3

" in TargetMol Product Catalog
  • Inhibitor Products
    26
    TargetMol | Activity
  • Peptides Products
    2
    TargetMol | inventory
AMPA receptor antagonist-3
T61813923272-18-8
AMPA receptor antagonist-3 is an AMPA receptor antagonist.
  • $195
In Stock
Size
QTY
Sigma-1 receptor antagonist 3
T129121639220-17-9In house
Sigma-1 receptor antagonist 3 is a potent and selective antagonist of Sigma-1 (σ1) receptor(Ki : 1.14 nM), has the potential for the neuropathic pain.
  • $81
In Stock
Size
QTY
TargetMol | Inhibitor Sale
GPR34 receptor antagonist 3
T82264
Compound 5e, a GPR34 receptor antagonist, exhibits selective inhibition of lysophosphatidylserine-induced ERK1/2 phosphorylation in a dose-dependent manner, demonstrating an IC50 value of 0.680 μM without significant cytotoxicity. Additionally, it displays antisensory activity in a mouse neuropathic pain model [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
RXFP1 receptor agonist-3
T812442924767-53-1
RXFP1 receptor agonist-3 (Example 223) is an agonist of the RXFP1 receptor that inhibits cyclic AMP (cAMP) production in HEK293 cells stably expressing human RXFP1, boasting an EC50 of 2 nM [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
EP4 receptor antagonist 3
T385951207954-34-4
EP4 receptor antagonist 3 is a highly potent and specific inhibitor of the EP4 receptor. It is intended for research purposes in studying EP4 receptor-mediated diseases such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, and cancer.
  • $970
Backorder
Size
QTY
TargetMol | Inhibitor Sale
Mu opioid receptor antagonist 3
T62767
Mu opioid receptor antagonist 3 (compound 26) is a potent and selective mu opioid receptor (MOR) antagonist that penetrates the blood-brain barrier (Ki: 0.24 nM, EC50: 0.54 nM). Mu opioid receptor antagonist 2 can be used to study opioid use disorder (OUD).
  • $1,520
10-14 weeks
Size
QTY
Adenosine receptor antagonist 3
T608722400864-80-2
Adenosine receptor antagonist 3 has the potential for cancer disease research which is a potent adenosine receptor antagonist [1].
  • $954
6-8 weeks
Size
QTY
TGR5 Receptor Agonist 3
T635542643391-08-4
TGR5 Receptor Agonist 3 is a G protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonist soft drug compound that decreases gallbladder filling, exhibits good gallbladder safety, and is able to act on hTGR5 (EC50: 16.4 nM) and mTGR5 (EC50: 209 nM).
  • $1,520
10-14 weeks
Size
QTY
Androgen receptor antagonist 3
T60987353484-46-5
Androgen receptor antagonist 3 (Compound C18) has anticancer activities that is an antagonist of androgen receptor (AR) (IC 50 = 2.4 μM) [1].
  • $2,140
6-8 weeks
Size
QTY
NMDA receptor modulator 3
T606852758256-02-7
NMDA receptor modulator 3 (Compound 99) is a potent modulator of NMDA receptor that can be used in the research of neurological disorder [1].
  • $1,520
6-8 weeks
Size
QTY
GLP-1 receptor agonist 3
T114042230200-09-4
GLP-1 receptor agonist 3 is a GLP-1 receptor agonist,Example 4A-1, has EC50s of 1.1 nM and 13 nM in Clone H6 and Clone C6 cell lines assay, respectively.
  • $1,820
8-10 weeks
Size
QTY
Estrogen receptor antagonist 3
T639142730011-50-2
Estrogen receptor antagonist 3 is a potent degradation agent of the estrogen receptor (ER). Estrogen signalling systems play an important role in the regulation of cell growth, differentiation and apoptosis, and Estrogen receptor antagonist 4 has shown potential for research into cancer diseases.
  • $2,140
8-10 weeks
Size
QTY
Androgen receptor degrader-3
T798912753650-84-7
Androgen Receptor Degrader-3 (ARD-3) is a compound that inhibits androgen receptor signaling and promotes the degradation of the receptor, with potential applications in prostate cancer research [1].
  • Inquiry Price
Size
QTY
Orexin receptor antagonist 3
T624531293282-55-9
Orexin receptor antagonist 3 (example 216) is an orexin receptor antagonist.
  • $1,620
6-8 weeks
Size
QTY
A2A receptor antagonist 3
T627972738606-83-0
A2A receptor antagonist 3 (Example 92) is an adenosine A2a receptor antagonist (Ki: 0.4 nM). receptor (Ki: 1467 nM).
  • $2,140
6-8 weeks
Size
QTY
Protease-Activated Receptor-1 antagonist 3
T63382
Protease-Activated Receptor-1 antagonist 3 is a potent antagonist (IC50: 7 nM) of Protease-Activated Receptor 1protease-activated receptor-1. antagonist 3 exhibits binding affinity to hERG K+ channels (IC50: 9 μM).
  • $1,520
10-14 weeks
Size
QTY
CB2 receptor agonist 3
T24097919077-81-9
GP 2A is a selective agonist of CB2 receptor.
  • $767
6-8 weeks
Size
QTY
NMDA receptor antagonist-3
T60792
NMDA receptor antagonist-3 is a NMDA receptor antagonist with a significan recovery rate (40.0%, at 100 μM) and safe toxicological characteristics in SH-SY5Y and human adipose mesenchymal stem cells.
  • $1,520
10-14 weeks
Size
QTY
ET receptor antagonist 3
T79575
ET receptor antagonist 3 (compound 17d) is an orally active ET receptor antagonist with an IC50 of 0.26 nM, utilized for pulmonary arterial hypertension (PAH) research. This compound demonstrates efficacy in mitigating monocrotaline-induced PAH in a rat model [1].
  • Inquiry Price
Size
QTY
Glucagon receptor antagonists-3
T11415202917-17-7
Glucagon receptor antagonist -3 is a highly effective glucagon receptor antagonist.
  • $755
8-10 weeks
Size
QTY
Protease-Activated Receptor-3 (PAR-3) (1-6), human
T362861872435-09-0
TFRGAP-amide, human PAR-3-derived tethered ligand sequence which does not activate PAR-3 but rather activates PAR-1 and PAR-2, either in Jurkat or in other PAR-expressing cells.
  • $580
35 days
Size
QTY
P2X7 receptor antagonist-3
T721981627900-92-8
P2X7 receptor antagonist-3 is a powerful inhibitor of the P2X7 receptor, exhibiting IC50 values of 4.2 nM in humans and 6.8 nM in rats, indicating its high potency in both species.
  • $1,520
6-8 weeks
Size
QTY
Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA
T36289
Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA is a peptide that acts as an agonist for the proteinase-activated receptor (PAR-3)[1].
  • $83
Backorder
Size
QTY
5-HT2A receptor agonist-3
T791551391499-52-7
5-HT2A receptor agonist-3 represents the highest selectivity for the human 5-HT2A receptor currently identified, exhibiting a K i of 2.5 nM. It also demonstrates a remarkable 124-fold selectivity over its structurally analogous 5-HT2C receptor [1].
  • Inquiry Price
Size
QTY
μ opioid receptor agonist 3
T794302378397-91-0
Compound 20, identified as μ opioid receptor agonist 3, is a potent µOR agonist that exhibits an EC50 value of 0.87 nM. It holds promise for research into pain management and neuropsychiatric disorders [1].
  • $1,520
8-10 weeks
Size
QTY
APJ receptor agonist 3
T635482759159-56-1
APJ receptor agonist 3 is a highly effective and orally administerable agonist of the APJ receptor, demonstrating a potent EC50 value of 0.027 nM.
  • $1,520
10-14 weeks
Size
QTY